Skip to main content
. 2025 Aug 25;17(8):e90956. doi: 10.7759/cureus.90956

Table 5. Incidence of adverse events during the study period.

Adverse event HPTC group (n = 40) dHACM group (n = 40)
Mild erythema Two patients (5.0%) Four patients (10.0%)
Mild allergic reaction None (0%) Two patients (5.0%)
Major events None (0%) None (0%)
Total Two patients (5.0%) Six patients (15.0%)